EP2964207A1 - Zusammensetzung zur verwendung bei der behandlung von polyzystischem ovarialsyndrom - Google Patents

Zusammensetzung zur verwendung bei der behandlung von polyzystischem ovarialsyndrom

Info

Publication number
EP2964207A1
EP2964207A1 EP14719069.8A EP14719069A EP2964207A1 EP 2964207 A1 EP2964207 A1 EP 2964207A1 EP 14719069 A EP14719069 A EP 14719069A EP 2964207 A1 EP2964207 A1 EP 2964207A1
Authority
EP
European Patent Office
Prior art keywords
formulation
lipoic acid
polycystic ovary
ovary syndrome
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP14719069.8A
Other languages
English (en)
French (fr)
Inventor
Lorenzo Secondini
Luigi Amelotti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laborest Italia SRL
Original Assignee
Laborest Italia SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laborest Italia SRL filed Critical Laborest Italia SRL
Publication of EP2964207A1 publication Critical patent/EP2964207A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
EP14719069.8A 2013-03-07 2014-03-07 Zusammensetzung zur verwendung bei der behandlung von polyzystischem ovarialsyndrom Withdrawn EP2964207A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000349A ITMI20130349A1 (it) 2013-03-07 2013-03-07 Composizione per uso nel trattamento della sindrome dell ovaio policistico
PCT/IB2014/000257 WO2014135956A1 (en) 2013-03-07 2014-03-07 Composition for use in the treatment of polycystic ovary syndrome

Publications (1)

Publication Number Publication Date
EP2964207A1 true EP2964207A1 (de) 2016-01-13

Family

ID=48579220

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14719069.8A Withdrawn EP2964207A1 (de) 2013-03-07 2014-03-07 Zusammensetzung zur verwendung bei der behandlung von polyzystischem ovarialsyndrom

Country Status (5)

Country Link
EP (1) EP2964207A1 (de)
BR (1) BR112015021722A2 (de)
IT (1) ITMI20130349A1 (de)
RU (1) RU2015140499A (de)
WO (1) WO2014135956A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7203521B2 (ja) * 2018-06-29 2023-01-13 小林製薬株式会社 Ｄ－ｃｈｉｒｏ－イノシトールを含む組成物
CN109517740B (zh) * 2018-12-05 2020-11-27 广东天益生物科技有限公司 一株紫色红曲霉诱变株和一种水溶性功能红曲及其制备方法和应用
IT201900025063A1 (it) * 2019-12-20 2021-06-20 Idi Integratori Dietetici Italiani S R L Composizioni gastroresistenti comprendi inositolo e/o estratto di gymnema sylvestre, loro composizioni farmaceutiche e nutraceutiche e loro uso
US11918018B2 (en) * 2022-05-17 2024-03-05 Provation Life LLC Nutraceutical compositions and methods for dietary alleviation of polycystic ovary syndrome

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1403587B1 (it) * 2010-12-17 2013-10-31 Laborest Italia S P A Composizione per il trattamento di disordini metabolici

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
None *
See also references of WO2014135956A1 *

Also Published As

Publication number Publication date
BR112015021722A2 (pt) 2017-07-18
ITMI20130349A1 (it) 2014-09-08
RU2015140499A (ru) 2017-04-12
WO2014135956A1 (en) 2014-09-12

Similar Documents

Publication Publication Date Title
KR20200029547A (ko) 베타-히드록시부티레이트 및 부탄디올의 s-거울상이성질체 및 이의 사용 방법
JP2001513487A (ja) 糖尿病治療用組成物及び治療方法
US11931342B2 (en) Magnesium biotinate compositions and methods of use
WO2014135956A1 (en) Composition for use in the treatment of polycystic ovary syndrome
RU2586742C2 (ru) Композиция для лечения метаболических расстройств
JP2014527506A (ja) 糖尿病治療のための組み合わせ
US9271948B2 (en) Agent for improving vesicourethral dyssynergia
AU2022200277A1 (en) The use of a benzoate containing composition to treat glycine encephalopathy
RU2493841C1 (ru) Синергетический препарат для лечения сердечно-сосудистых заболеваний, сахарного диабета и заболеваний гепато-билиарной системы
EP3429625B1 (de) Verfahren zur behandlung von adipositas
JP2022523303A (ja) グルコース代謝障害の長時間作用型の予防または治療に使用するためのβ－ラクタム化合物またはその塩
CN112691102A (zh) 黄芩素在防治帕金森病/帕金森综合征抑郁症状中的应用
Hedaiaty Administration of metformin in clinical medicine; an updated mini-review on current findings
DK2537528T3 (en) Pharmaceutical compositions containing beta and alpha-galactosidase and their use in the treatment of gastroesophageal reflux disease
WO2018192469A1 (en) Inhibitors of fabp4 and methods of treating arthritis
US20230110351A1 (en) Methods for treating parkinson's disease with sepiapterin
WO2023230560A1 (en) Treatment of organic acidemias or pantothenate kinase associated neurodegeneration with modulators of pantothenate kinases
TW202033199A (zh) 化合物ａ與化合物ｂ聯合在製備治療痛風或高尿酸血症的藥物中的用途
ITMI20130241A1 (it) Composizione per il trattamento di disordini metabolici
CN117500491A (zh) 用于预防脂肪肝病、预防脂肪肝病进展和治疗脂肪肝病的地那铵盐

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20150828

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: LABOREST ITALIA S.R.L.

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20180430

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20181113